AstraZeneca PLC Boss: We "Double and Triple Checked" Chinese Controls

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The boss of AstraZeneca (LON:AZN) stated his confidence in the drugmaker’s compliance systems in China, easing concerns it is next in line for a dressing down. Chief executive Pascal Soriot said the company had “double and triple checked” its controls in the wake of the scandal that has thrown rival pharmaceutical giant GlaxoSmithKline into turmoil. Glaxo is under investigation for allegedly bribing doctors and hospitals to boost sales of drugs and vaccines in its fastest-growing market.

Help employers find you! Check out all the jobs and post your resume.

Back to news